Human V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) ELISA Kit

Mutations in the KRAS oncogene are among the most frequently characterised drivers of human cancers, particularly pancreatic ductal adenocarcinoma, colorectal carcinoma, and non-small cell lung cancer. This Assay Genie kit provides a quantitative ELISA workflow for research teams studying KRAS protein expression in vitro or in tumour biology models.

The reagent set supports cell culture-derived samples, tissue homogenates prepared from xenografts or primary tumour material, serum-based preparations, and plasma fractions, making it appropriate for translational oncology studies where matched sample matrices are profiled in parallel. Researchers investigating Ras-MAPK signalling, biomarker validation, or therapeutic target engagement can incorporate the kit alongside existing immunohistochemistry, western blot, or PCR workflows for orthogonal confirmation of their findings.

Each kit is supplied as a complete reagent set intended for research use only in laboratory settings.